Showing results (341-350 of 447) with videos related to
Sort By:
Pageof 45
Therapeutic Advances in Medical Oncology|December 30, 2024
Analysis of outcomes in resected early-stage NSCLC with rare targetable driver mutationsNadia Ghazali, Jamie Feng, Katrina Hueniken, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapyFrances A Shepherd, Caroline Domerg, Pierre Hainaut, et al.Archives of Pathology & Laboratory Medicine|July 22, 2016
Transbronchial Lung Cryobiopsy for Interstitial Lung Disease Diagnosis: A Perspective From Members of the Pulmonary Pathology SocietyKirtee Raparia, Dara L Aisner, Timothy Craig Allen, et al.Nature Medicine|October 27, 2015
Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoidsLing Huang, Audrey Holtzinger, Ishaan Jagan, et al.JCO Precision Oncology|January 20, 2022
Multicenter Validation Study to Implement Plasma Epidermal Growth Factor Receptor T790M Testing in Clinical LaboratoriesNatasha B Leighl, Suzanne Kamel-Reid, Parneet K Cheema, et al.Therapeutic Advances in Medical Oncology|September 26, 2022
Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsyMiguel Garcia-Pardo, Kasia Czarnecka, Jennifer H Law, et al.Archives of Pathology & Laboratory Medicine|April 16, 2016
Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology SocietySinchita Roy-Chowdhuri, Dara L Aisner, Timothy Craig Allen, et al.Science Translational Medicine|November 17, 2021
Assessing therapy response in patient-derived xenograftsJanosch Ortmann, Ladislav Rampášek, Elijah Tai, et al.Lung Cancer (Amsterdam, Netherlands)|May 25, 2020
EGFR-mutated lung adenocarcinomas from patients who progressed on EGFR-inhibitors show high engraftment rates in xenograft modelsSebastiao N Martins-Filho, Jessica Weiss, Nhu-An Pham, et al.JTO Clinical and Research Reports|December 17, 2021
Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and EfficacySally C M Lau, Malcolm Ryan, Jessica Weiss, et al.Pageof 45